The first Lyfebulb Novo-Nordisk Innovation Summit in Copenhagen, Denmark has wrapped! After a few jam-packed days that included dinners, workshops, speeches by Lyfebulb founder and CEO, Karin Hehenberger, and Novo Nordisk Senior Vice President, Device R&D, Kenneth Strømdahl, as well as pitches from each of our ten patient entrepreneur finalists, we have a WINNER!
Congratulations to Brianna Wolin, CEO and co-founder of Find Your Ditto, who received the first ever Lyfebulb-Novo Nordisk Innovation Award! Wolin’s company is a mobile platform for connecting individuals living with the same chronic illness locally for on-demand, in-person peer support.
“To be recognized by an innovative organization such as Lyfebulb and Novo Nordisk, a global pharmaceutical leader in diabetes care, is a true honor and an affirmation that our work to helping change the landscape surrounding isolation and depression in chronic illness communities is fully worthwhile,” said Brianna Wolin. “I’m so proud to have our mission – creating a world where no person living with a chronic illness ever has to feel alone – highlighted by this award.”
The competition was judged by five key opinion leaders and influences in the diabetes community, and Wolin was selected from a distinguished group of patient entrepreneur finalists that included:
- Shilo Ben-Zeev, Smartzyme, Israel;
- Jeff Dachis, OneDrop, USA;
- Shantanu Gaur, MD, Allurion, USA;
- Matt Loper, Wellth, USA;
- Charles O’Connell, FitScript, USA;
- Scott Smith, Socrates, USA;
- Anna Sjoberg, Anna PS, Sweden;
- John Sjolund, Patients Pending Ltd, UK;
- David Weingard, Fit4D, USA.
We are very proud of all who participated! Every one of them is truly doing magnificent work in advancing the management and care of diabetes.
Once again, congratulations Brianna! We are looking forward to the growth and success of Find Your Ditto!